Universal Biosensors, Inc. (ASX: UBI) announced today that LifeScan, Inc had provided information
concerning its strategic intentions for Its OneTouch® Verio™ product developed with UBI.
This occurred during the Diabetes Care Franchise Review, which was part of the Johnson & Johnson
Medical Devices and Diagnostics Business Review with analysts.
Read the full report
All News